查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1857608

永續醫藥包裝市場：依包裝類型、材料、藥品類型、最終用戶和技術分類－2025-2032年全球預測

Sustainable Pharmaceutical Packaging Market by Packaging Type, Material, Drug Type, End User, Technology - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，永續藥品包裝市場規模將達到 2,352.8 億美元，複合年成長率為 13.45%。

主要市場統計數據
基準年 2024 857億美元
預計年份：2025年 974.9億美元
預測年份：2032年 2352.8億美元
複合年成長率 (%) 13.45%

本文簡要闡述了為何永續藥品包裝需要一種涵蓋安全、監管和環境優先事項的綜合營運方法。

藥品包裝處於病人安全、法規遵循、供應鏈韌性和環境保護的交會點。隨著相關人員對產品完整性和永續性的要求越來越高，包裝選擇不僅影響營運成本和物流，也日益影響品牌信任度和監管機構的認可。本執行摘要了正在重塑整個藥品價值鏈包裝策略的根本性轉變，重點闡述了材料創新、技術整合和政策動態如何共同作用，重新定義「適用包裝」的含義。

永續材料、活性阻隔技術和數位化可追溯性的整合如何重新定義藥品包裝性能和供應商關係

受環境影響監管日益嚴格、材料創新日新月異以及數位化溯源解決方案普及等多重因素共同驅動，醫藥包裝領域正經歷一系列變革。在整個價值鏈中，人們正切實地從單一用途的包裝轉向兼具保護、延長保存期限和循環利用功能的多功能系統。諸如可生物分解聚合物和增強玻璃配方等材料，不僅要評估其阻隔性能，還要評估其報廢處理途徑和碳排放影響。

評估近期關稅調整和貿易政策轉變如何促進包裝行業的供應鏈本地化、供應商多元化和材料認證計劃。

到2025年，關稅的累積變動和貿易政策調整正在改變醫藥包裝材料和組件的成本動態以及供應商的決策。對某些進口原料和組件徵收更高的課稅，促使下游企業重新評估總到岸成本、前置作業時間和庫存策略。為此，許多企業正在加快供應商多元化，優先選擇地理位置相近且垂直整合的合作夥伴，以減輕貿易摩擦和運費波動的影響。

綜合細分分析揭示了包裝類型、材料選擇、藥物配方、終端用戶需求和新興技術之間的交集，從而指南策略投資。

精細化的細分視角清楚地展現了創新與風險的交會點，從而明確了優先研發方向與採購管道。包裝類型涵蓋安瓿、泡殼包裝、瓶裝、軟袋和管瓶，每種類型又細分為玻璃和塑膠安瓿、紙質和多層泡殼結構、玻璃和塑膠瓶、鋁箔和紙質軟袋以及玻璃和塑膠管瓶子類型。這些區分至關重要，因為不同包裝形式的阻隔性能、滅菌相容性和回收途徑差異顯著。材料選擇包括生物分解性塑膠，例如PHA、PLA和澱粉基聚合物；玻璃材料，例如硼矽酸、燧石玻璃和鈉鈣玻璃；金屬，例如鋁和鋼；以及紙基基材，例如瓦楞紙和牛皮紙。這些選擇需要在耐用性、滲透性、可回收性和生命週期足跡之間進行權衡。

影響美洲、歐洲、中東和非洲以及亞太市場包裝決策的區域優先事項和監管環境

區域動態對包裝設計、採購和技術應用的策略選擇有顯著影響。在美洲，監管機構的期望以及對永續性報告的強烈要求，正促使製造商和合約包裝商投資於可回收包裝形式，並與本土材料供應商建立合作關係。市場對低溫運輸可靠性和大型零售藥局通路的重視，也推動了穩健的二次包裝和可追溯性解決方案的發展。在歐洲、中東和非洲，政策促進因素和生產者延伸責任框架正在加速可重複使用和可回收材料的普及，而嚴格的管理體制則要求進行有效的安全性和適用性測試。

市場領導如何協調垂直整合、共同開發夥伴關係、可追溯性投資和驗證服務，從而在包裝領域獲得競爭優勢？

醫藥包裝生態系統中的主要企業正在採取不同但互補的策略，以克服性能、永續性和監管方面的複雜性。一些公司正在垂直整合材料生產和加工能力，以確保供應的連續性並縮短新材料的認證週期。另一些公司則專注於與聚合物創新者和玻璃製造商建立策略夥伴關係和共同開發契約，以加速高效環保材料的推出。投資於中試生產線和模組製造已成為縮短檢驗時間並限制資本投入的常用策略。

針對採購、研發和監管團隊，制定有針對性的、可操作的措施，以在包裝策略中平衡韌性、永續性和合規性。

產業領導者應採取組合策略，兼顧短期營運韌性與長期永續性轉型。首先，應優先考慮供應商多元化，透過對地理位置相近的替代供應商進行資質認證，並對高風險材料採取雙重採購安排，同時加快資質認證藍圖，以減少轉換阻力。其次，應投資進行有針對性的材料替代試點項目，利用跨職能團隊在實際穩定性及滅菌條件下評估可生物分解聚合物和先進玻璃配方，以加快技術檢驗並證明其符合監管要求。

採用透明的混合方法研究設計，結合專家訪談、供應鏈檢驗、技術評估和用例分析，確保獲得可操作、可複製的洞見。

本研究採用混合方法，將專家質性見解與結構化的供應鏈分析和技術評估結合。主要研究包括對高級包裝工程師、法規事務專家、採購負責人和供應商技術經理進行深入訪談，並輔以實地考察和虛擬研討會，以檢驗材料性能聲明和認證流程。次要研究包括對法規指南、技術標準、生命週期評估文獻以及已發布的材料安全和合規數據進行系統性回顧，以支持主要研究結果並為風險框架提供基礎。

本文對跨職能協作和漸進式實施對於實現包裝產品安全和永續性目標至關重要的原因進行了批判性綜合分析。

永續的藥品包裝不再是美好的願景，而是與品質、合規性和企業責任息息相關的商業要務。材料創新、技術賦能的可追溯性以及不斷變化的貿易動態正在重塑行業格局，這要求我們採用更靈活的夥伴關係以及更嚴格的檢驗流程。為了取得成功，包裝決策必須從整體角度出發，並被視為跨職能的投資，它會影響產品安全、病患療效和環境績效。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 用於泡殼包裝中控制釋放的可生物分解聚合物塗層
  • 將智慧感測器整合到可回收包裝中，用於即時監測藥品穩定性。
  • 開發用於注射管瓶防潮保護的植物來源纖維素薄膜
  • 高密度聚苯乙烯藥用容器閉合迴路回收系統的標準化
  • 引入輕質玻璃替代品，以減少注射劑包裝的碳足跡
  • 利用人工智慧最佳化供應鏈，最大限度地減少包裝廢棄物和碳排放
  • 鼓勵在藥品二級包裝中使用消費後回收材料的監管激勵措施
  • 先進的可食用塗層技術，可增強穩定性並減少包裝廢棄物

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依包裝類型分類的永續醫藥包裝市場

  • 安瓿
    • 玻璃安瓿
    • 塑膠安瓿
  • 泡殼包裝
    • 紙包
    • PVC鋁箔包裝
    • PVDC 電池組
  • 瓶子
    • 玻璃瓶
    • 塑膠瓶
  • 小袋
    • 鋁箔袋
    • 紙袋
  • 管瓶
    • 玻璃管瓶
    • 塑膠管瓶

第9章 依材料分類的永續醫藥包裝市場

  • 生物分解性塑膠
    • PHA
    • PLA
    • 澱粉基聚合物
  • 玻璃
    • 硼矽酸
    • 燧石
    • 蘇打石灰
  • 金屬
    • 鋁
    • 鋼
  • 紙板
    • 紙板
    • 牛皮紙

第10章 依藥品類型分類的永續藥品包裝市場

  • 液體
    • 解決方案
    • 暫停
  • 半固態
    • 奶油
    • 凝膠
    • 軟膏
  • 固態劑型
    • 膠囊
    • 藥片

第11章永續醫藥包裝市場：依最終用戶分類

  • 診所
  • 醫院
  • 網路藥房
  • 研究所
  • 零售藥房

第12章永續醫藥包裝市場（依技術分類）

  • 活性包裝
    • 乙烯清除劑
    • 氧氣清除劑
  • 智慧包裝
    • NFC
    • QR碼
    • RFID
  • 調氣包裝
    • 調氣包裝容器
    • 調氣包裝膜
  • 真空包裝
    • 蓋膜
    • 真空袋

第13章永續醫藥包裝市場：依地區分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章永續醫藥包裝市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國永續醫藥包裝市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Amcor plc
    • Berry Global Group, Inc.
    • Mondi plc
    • Gerresheimer AG
    • West Pharmaceutical Services, Inc.
    • AptarGroup, Inc.
    • SCHOTT AG
    • Constantia Flexibles Group GmbH
    • Tekni-Plex, Inc.
    • ALPLA Werke Alwin Lehner GmbH & Co KG
Product Code: MRR-67236922860E

The Sustainable Pharmaceutical Packaging Market is projected to grow by USD 235.28 billion at a CAGR of 13.45% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 85.70 billion
Estimated Year [2025] USD 97.49 billion
Forecast Year [2032] USD 235.28 billion
CAGR (%) 13.45%

A concise orientation to why sustainable pharmaceutical packaging now demands integrated operational approaches across safety, regulation, and environmental priorities

Pharmaceutical packaging sits at the intersection of patient safety, regulatory compliance, supply chain resilience, and environmental stewardship. As stakeholders demand higher standards for product integrity and sustainability, packaging choices increasingly determine not only operational cost and logistics, but also brand trust and regulatory acceptance. This executive summary distills the structural shifts reshaping packaging strategies across the pharmaceutical value chain, highlighting how material innovation, technology integration, and policy dynamics coalesce to redefine what "fit for purpose" packaging entails.

The analysis that follows frames both immediate and strategic considerations for manufacturers, contract packagers, material suppliers, and healthcare providers. It emphasizes pragmatic pathways to balance product protection with environmental responsibility, showing how firms can reduce systemic risk without compromising compliance. By synthesizing technological trajectories, supply chain pressures, and regional policy contexts, the summary equips leaders with an actionable perspective to align short-term operational choices with longer-term sustainability commitments. Readers should expect clear, implementable insights intended to guide sourcing, R&D prioritization, and cross-functional coordination.

How convergence of sustainable materials, active barrier technologies, and digital traceability is redefining pharmaceutical packaging performance and supplier relationships

The pharmaceutical packaging landscape is undergoing a series of transformative shifts driven by converging forces: heightened regulatory scrutiny for environmental impact, rapid material innovation, and the proliferation of digital traceability solutions. Across the value chain, there is a tangible move from single-purpose containers toward multifunctional systems that combine protection, extended shelf life, and circularity. Materials such as biodegradable polymers and enhanced glass formulations are being evaluated not only for barrier performance but also for end-of-life pathways and carbon implications.

Parallel to material change, packaging technologies that actively manage product micro-environments and provide real-time information are gaining traction. Active packaging components like oxygen and ethylene scavengers and intelligent layers enabled by NFC and RFID are being integrated to improve stability and reduce waste. Moreover, manufacturers increasingly favor modular design and compatibility with sterilization methods to streamline manufacturing and logistics. These shifts are prompting a re-evaluation of supplier relationships, quality assurance protocols, and capital allocation decisions, as firms balance the imperative for sustainability with the uncompromising requirements of patient safety and regulatory compliance.

Assessing how recent tariff adjustments and trade policy shifts have catalyzed supply chain localization, supplier diversification, and material qualification programs in packaging

Cumulative tariff activity and trade policy adjustments in 2025 have altered cost dynamics and supplier decisions for pharmaceutical packaging materials and components. Increased levies on certain imported raw materials and components have encouraged downstream players to reassess total landed cost, lead times, and inventory strategies. In response, many organizations have accelerated supplier diversification efforts, prioritizing geographically proximate and vertically integrated partners to mitigate exposure to trade friction and freight volatility.

The tariff-driven rebalancing has also amplified interest in material substitution where domestic availability is strong; for example, sourcing alternatives to certain coated films and metal components has become more attractive when tariff differentials erode cost advantages of long-distance suppliers. At the same time, regulatory compliance considerations and the need for validated material equivalence mean that transitions cannot be purely cost-driven. Firms have increased investment in qualification protocols and in collaborative trials with material suppliers to ensure that changes in sourcing do not compromise drug stability or packaging integrity. Ultimately, trade measures in 2025 served as a catalyst for greater supply chain localization, stronger supplier partnerships, and more disciplined scenario planning across procurement and regulatory teams.

An integrated segmentation analysis revealing where packaging types, material choices, drug formulations, end-user needs, and emerging technologies intersect to guide strategic investment

A granular segmentation lens clarifies where innovation and risk converge and illuminates priority pathways for development and procurement. Packaging types span ampoules, blister packs, bottles, pouches, and vials, each with subtypes such as glass versus plastic ampoules, paper and multi-layer blister constructions, glass and plastic bottles, foil and paper pouches, and glass and plastic vials; these distinctions matter because barrier needs, sterilization compatibility, and recycling routes vary significantly across formats. Material choices encompass biodegradable plastics-including PHA, PLA, and starch-based polymers-glass variants like borosilicate, flint, and soda lime, metals such as aluminum and steel, and paper-based substrates including corrugated board and kraft paper; these materials drive trade-offs between durability, permeability, recyclability, and life-cycle footprint.

Drug type segmentation-liquid dosage formulations (solutions and suspensions), semi-solid forms (creams, gels, ointments), and solid dosages (capsules and tablets)-creates distinct stability demands that influence container selection, barrier specification, and secondary packaging. End users range from clinics and hospitals to online and retail pharmacies, and research laboratories, each imposing unique handling, storage, and patient-facing requirements that shape packaging ergonomics and labeling. Technology-driven categories include active packaging with ethylene and oxygen scavengers, intelligent solutions leveraging NFC, QR, and RFID for authentication and data capture, modified atmosphere options via MAP containers and films, and vacuum systems employing lidding films and vacuum pouches; selecting among these technologies requires aligning functional performance with cost, regulatory considerations, and sustainability objectives. By examining these segments together, firms can prioritize innovation investments where material and format transitions yield the greatest impact on performance, compliance, and environmental outcomes.

Regional priorities and regulatory contexts that shape packaging decisions across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics substantially influence strategic choices in packaging design, sourcing, and technology adoption. In the Americas, regulatory expectations and strong demand for sustainability reporting have prompted manufacturers and contract packagers to invest in recyclable formats and to pursue partnerships with domestic material suppliers; the market's emphasis on cold-chain reliability and large retail pharmacy channels also favors robust secondary packaging and traceability solutions. In Europe, Middle East & Africa, policy drivers and extended producer responsibility frameworks are accelerating the adoption of reusable and recyclable materials, while stringent regulatory regimes insist on validated safety and compatibility testing; manufacturers operating in this region often prioritize materials with clear end-of-life pathways and suppliers that can provide lifecycle documentation.

Across Asia-Pacific, rapid growth in local pharmaceutical manufacturing and a diverse range of end-user infrastructures have led to a dual focus on cost-effective materials and scalable technology solutions. In several markets, novel biodegradable polymers are being trialed at scale, and there is brisk adoption of intelligent labeling to support anti-counterfeiting and remote patient engagement. Regional supply chains in Asia-Pacific also play a pivotal role in global sourcing, making supplier qualification and quality assurance critical for multinational firms that rely on components produced there. Together, these regional nuances require multinational packaging strategies that balance centralized standards with localized execution and supplier ecosystems.

How market leaders are aligning vertical integration, co-development partnerships, traceability investments, and validation services to gain competitive advantage in packaging

Leading companies in the pharmaceutical packaging ecosystem are pursuing distinct but complementary strategies to navigate performance, sustainability, and regulatory complexity. Some players are vertically integrating material production and converting capabilities to secure supply continuity and to reduce qualification cycles for new materials. Others focus on strategic partnerships and co-development agreements with polymer innovators and glass manufacturers to accelerate the introduction of validated, low-impact materials. Investment in pilot lines and modular manufacturing has become a common tactic to shorten time-to-validation while limiting capital exposure.

Across the competitive landscape, firms are differentiating through certification and traceability credentials, leveraging technologies like RFID and cryptographic QR implementations to meet anti-counterfeiting and provenance demands. Another common thread is the emphasis on technical service: suppliers offering comprehensive validation support, stability study collaboration, and regulatory dossier assistance are gaining preference among pharmaceutical companies. Mergers and targeted acquisitions are also shaping the sector, enabling buyers to expand technology portfolios and regional footprints. Collectively, these company-level tactics reflect a shift from transactional supply models to partnership-focused engagements that align commercial terms with long-term technical collaboration and sustainability outcomes.

Targeted, actionable measures for procurement, R&D, and regulatory teams to balance resilience, sustainability, and compliance in packaging strategies

Industry leaders should adopt a portfolio approach that balances immediate operational resilience with longer-term sustainability transitions. First, prioritize supplier diversification by qualifying alternative vendors across regionally proximate geographies and by establishing dual-sourcing arrangements for high-risk materials; simultaneously develop accelerated qualification roadmaps that reduce switching friction. Next, invest in targeted material substitution pilots that evaluate biodegradable polymers and advanced glass formulations under real-world stability and sterilization conditions, using cross-functional teams to expedite technical validation and to document regulatory equivalence.

Leaders should also scale intelligent packaging pilots that deliver measurable returns, such as reduced counterfeiting risk, improved cold-chain monitoring, or lower product loss, then expand those solutions where ROI is demonstrated. Implement robust end-of-life strategies by collaborating with recycling value chains and by specifying mono-material constructions when possible to enhance recyclability. To manage trade and tariff exposure, enact scenario-based procurement plans and maintain buffer inventories for critical components while negotiating flexible commercial terms. Finally, embed clear sustainability metrics into supplier scorecards and purchasing decisions, align R&D roadmaps with regulatory trajectories, and maintain active dialogue with regulators and industry consortia to shape practical, harmonized standards.

A transparent mixed-methods research design combining expert interviews, supply chain validation, technical assessments, and case studies to ensure practical, reproducible insights

This research employs a mixed-methods approach that synthesizes qualitative expert insight with structured supply chain analysis and technical assessment. Primary research consisted of in-depth interviews with senior packaging engineers, regulatory affairs specialists, procurement leads, and supplier technical managers, complemented by site visits and virtual workshops to validate material performance claims and qualification workflows. Secondary research included a systematic review of regulatory guidance, technical standards, lifecycle assessment literature, and published material safety and compatibility data to corroborate primary findings and to inform risk frameworks.

Data triangulation was used throughout to reconcile differing perspectives and to ensure that technical recommendations reflect real-world constraints. Case studies were developed to illustrate successful transitions in materials and technologies, including detailed accounts of validation pathways and commercial arrangements. Limitations include variability in regional regulatory timelines and emerging data on novel biodegradable polymers; where evidence remains nascent, recommendations emphasize pilot testing and staged qualification. The methodology prioritizes reproducibility and transparency, and documentation is provided so practitioners can adapt evaluation sequences to their internal governance and risk tolerance.

A decisive synthesis of why cross-functional alignment and phased implementation are essential to realize both product safety and sustainability objectives in packaging

Sustainable pharmaceutical packaging is no longer an aspirational goal; it is an operational imperative that intersects quality, compliance, and corporate responsibility. The landscape is being reshaped by material innovations, technology-enabled traceability, and shifting trade dynamics that together demand more agile sourcing, stronger supplier partnerships, and rigorous validation practices. Success requires organizations to think holistically about packaging decisions, treating them as cross-functional investments that affect product safety, patient outcomes, and environmental performance.

By integrating the segmentation insights, regional nuances, and company tactics described above, decision-makers can construct phased strategies that mitigate near-term risks while building capacity for long-term transformation. Incremental pilots, robust supplier qualification, and targeted technology deployment will allow firms to both satisfy regulatory requirements and achieve measurable sustainability improvements. The most resilient companies will be those that align commercial incentives with technical collaboration and that institutionalize continuous learning between procurement, R&D, and regulatory teams.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of biodegradable polymer coatings for controlled drug release in blister packs
  • 5.2. Integration of smart sensors in recyclable packaging to monitor drug stability in real time
  • 5.3. Development of plant-based cellulose films for moisture barrier protection in injectable vials
  • 5.4. Standardization of closed loop recycling systems for high-density polyethylene drug containers
  • 5.5. Implementation of lightweight glass alternatives to reduce carbon footprint in parenteral packaging
  • 5.6. Use of AI-driven supply chain optimization to minimize packaging waste and carbon emissions
  • 5.7. Regulatory incentives for using post-consumer recycled content in pharmaceutical secondary packaging
  • 5.8. Advancements in edible coating technologies to enhance stability and reduce packaging disposables

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Sustainable Pharmaceutical Packaging Market, by Packaging Type

  • 8.1. Ampoules
    • 8.1.1. Glass Ampoules
    • 8.1.2. Plastic Ampoules
  • 8.2. Blister Packs
    • 8.2.1. Paper Packs
    • 8.2.2. Pvc Aluminum Packs
    • 8.2.3. Pvdc Packs
  • 8.3. Bottles
    • 8.3.1. Glass Bottles
    • 8.3.2. Plastic Bottles
  • 8.4. Pouches
    • 8.4.1. Foil Pouches
    • 8.4.2. Paper Pouches
  • 8.5. Vials
    • 8.5.1. Glass Vials
    • 8.5.2. Plastic Vials

9. Sustainable Pharmaceutical Packaging Market, by Material

  • 9.1. Biodegradable Plastics
    • 9.1.1. Pha
    • 9.1.2. Pla
    • 9.1.3. Starch Based Polymers
  • 9.2. Glass
    • 9.2.1. Borosilicate
    • 9.2.2. Flint
    • 9.2.3. Soda Lime
  • 9.3. Metal
    • 9.3.1. Aluminum
    • 9.3.2. Steel
  • 9.4. Paper Cardboard
    • 9.4.1. Corrugated Board
    • 9.4.2. Kraft Paper

10. Sustainable Pharmaceutical Packaging Market, by Drug Type

  • 10.1. Liquid Dosage
    • 10.1.1. Solutions
    • 10.1.2. Suspensions
  • 10.2. Semi Solid Dosage
    • 10.2.1. Creams
    • 10.2.2. Gels
    • 10.2.3. Ointments
  • 10.3. Solid Dosage
    • 10.3.1. Capsules
    • 10.3.2. Tablets

11. Sustainable Pharmaceutical Packaging Market, by End User

  • 11.1. Clinics
  • 11.2. Hospitals
  • 11.3. Online Pharmacies
  • 11.4. Research Laboratories
  • 11.5. Retail Pharmacies

12. Sustainable Pharmaceutical Packaging Market, by Technology

  • 12.1. Active Packaging
    • 12.1.1. Ethylene Scavengers
    • 12.1.2. Oxygen Scavengers
  • 12.2. Intelligent Packaging
    • 12.2.1. Nfc
    • 12.2.2. Qr Code
    • 12.2.3. Rfid
  • 12.3. Modified Atmosphere Packaging
    • 12.3.1. Map Containers
    • 12.3.2. Map Films
  • 12.4. Vacuum Packaging
    • 12.4.1. Lidding Films
    • 12.4.2. Vacuum Pouches

13. Sustainable Pharmaceutical Packaging Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Sustainable Pharmaceutical Packaging Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Sustainable Pharmaceutical Packaging Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Amcor plc
    • 16.3.2. Berry Global Group, Inc.
    • 16.3.3. Mondi plc
    • 16.3.4. Gerresheimer AG
    • 16.3.5. West Pharmaceutical Services, Inc.
    • 16.3.6. AptarGroup, Inc.
    • 16.3.7. SCHOTT AG
    • 16.3.8. Constantia Flexibles Group GmbH
    • 16.3.9. Tekni-Plex, Inc.
    • 16.3.10. ALPLA Werke Alwin Lehner GmbH & Co KG

LIST OF FIGURES

  • FIGURE 1. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS AMPOULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS AMPOULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS AMPOULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS AMPOULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS AMPOULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS AMPOULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC AMPOULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC AMPOULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC AMPOULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC AMPOULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC AMPOULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC AMPOULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER PACKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER PACKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER PACKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER PACKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER PACKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER PACKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVC ALUMINUM PACKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVC ALUMINUM PACKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVC ALUMINUM PACKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVC ALUMINUM PACKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVC ALUMINUM PACKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVC ALUMINUM PACKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVDC PACKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVDC PACKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVDC PACKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVDC PACKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVDC PACKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVDC PACKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS BOTTLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS BOTTLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS BOTTLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS BOTTLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS BOTTLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS BOTTLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC BOTTLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC BOTTLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC BOTTLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC BOTTLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC BOTTLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC BOTTLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FOIL POUCHES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FOIL POUCHES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FOIL POUCHES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FOIL POUCHES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FOIL POUCHES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FOIL POUCHES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER POUCHES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER POUCHES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER POUCHES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER POUCHES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER POUCHES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER POUCHES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS VIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS VIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS VIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS VIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS VIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS VIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC VIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC VIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC VIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC VIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC VIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC VIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BIODEGRADABLE PLASTICS, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BIODEGRADABLE PLASTICS, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BIODEGRADABLE PLASTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BIODEGRADABLE PLASTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BIODEGRADABLE PLASTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BIODEGRADABLE PLASTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BIODEGRADABLE PLASTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BIODEGRADABLE PLASTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STARCH BASED POLYMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STARCH BASED POLYMERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STARCH BASED POLYMERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STARCH BASED POLYMERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STARCH BASED POLYMERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STARCH BASED POLYMERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOROSILICATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOROSILICATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOROSILICATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOROSILICATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOROSILICATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOROSILICATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FLINT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FLINT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FLINT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FLINT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FLINT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FLINT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SODA LIME, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SODA LIME, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SODA LIME, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SODA LIME, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SODA LIME, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SODA LIME, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY METAL, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY METAL, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY METAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY METAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY METAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY METAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY METAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY METAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY ALUMINUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY ALUMINUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY ALUMINUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY ALUMINUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY ALUMINUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY ALUMINUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STEEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STEEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STEEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STEEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER CARDBOARD, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER CARDBOARD, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER CARDBOARD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER CARDBOARD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER CARDBOARD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER CARDBOARD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER CARDBOARD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER CARDBOARD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CORRUGATED BOARD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CORRUGATED BOARD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CORRUGATED BOARD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CORRUGATED BOARD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CORRUGATED BOARD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CORRUGATED BOARD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY KRAFT PAPER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY KRAFT PAPER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY KRAFT PAPER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY KRAFT PAPER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY KRAFT PAPER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY KRAFT PAPER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SUSPENSIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SUSPENSIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SUSPENSIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SUSPENSIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SUSPENSIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI SOLID DOSAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI SOLID DOSAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI SOLID DOSAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI SOLID DOSAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI SOLID DOSAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI SOLID DOSAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CREAMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CREAMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CREAMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CREAMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CREAMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CREAMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY OINTMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY OINTMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY OINTMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY OINTMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY OINTMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID DOSAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID DOSAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID DOSAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID DOSAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID DOSAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID DOSAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CAPSULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CAPSULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CAPSULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY TABLETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY TABLETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY TABLETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY TABLETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CLINICS, BY COUN